Role of microRNAs in the immune system, inflammation and cancer.

MicroRNAs, a key class of gene expression regulators, have emerged as crucial players in various biological processes such as cellular proliferation and differentiation, development and apoptosis. In addition, microRNAs are coming to light as crucial regulators of innate and adaptive immune responses, and their abnormal expression and/or function in the immune system have been linked to multiple human diseases including inflammatory disorders, such as inflammatory bowel disease, and cancers. In this review, we discuss our current understanding of microRNAs with a focus on their role and mode of action in regulating the immune system during inflammation and carcinogenesis.

[1]  Chengzhong Xing,et al.  Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers , 2010, Journal of Gastrointestinal Surgery.

[2]  N. Miller,et al.  Circulating miR‐34a levels are reduced in colorectal cancer , 2012, Journal of surgical oncology.

[3]  Ryan M. O’Connell,et al.  MicroRNA-34 a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp 1 , 2010 .

[4]  E. Ogier-Denis,et al.  Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease , 2010, PloS one.

[5]  A. Rudensky,et al.  Dicer-dependent microRNA pathway safeguards regulatory T cell function , 2008, The Journal of experimental medicine.

[6]  A. Pasquinelli,et al.  Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing , 2001, Cell.

[7]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[8]  Y. Nakagawa,et al.  Association Study of Common Genetic Variants in Pre-microRNAs in Patients with Ulcerative Colitis , 2011, Journal of Clinical Immunology.

[9]  G. Krystal,et al.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance. , 2004, Immunity.

[10]  Kishore Guda,et al.  The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers , 2008, Genes, chromosomes & cancer.

[11]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[12]  G. Ruvkun,et al.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.

[13]  A. Holmgren,et al.  S-Nitrosoglutathione Is Cleaved by the Thioredoxin System with Liberation of Glutathione and Redox Regulating Nitric Oxide* , 1996, The Journal of Biological Chemistry.

[14]  N. Rajewsky,et al.  Regulation of the Germinal Center Response by MicroRNA-155 , 2007, Science.

[15]  A. Vercesi,et al.  Mitochondria and reactive oxygen species. , 2009, Free radical biology & medicine.

[16]  N. Miller,et al.  MicroRNA-21 and PDCD4 expression in colorectal cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  Judy H. Cho,et al.  Inflammatory bowel disease: an update on the fundamental biology and clinical management. , 2011, Gastroenterology.

[18]  P. Portincasa,et al.  Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. , 2005, Clinical biochemistry.

[19]  A. Rudensky,et al.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells , 2007, Nature.

[20]  Frank J. Sørensen,et al.  Diagnostic and prognostic microRNAs in stage II colon cancer. , 2008, Cancer research.

[21]  Muller Fabbri,et al.  Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.

[22]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[23]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[24]  L. Muglia,et al.  Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice , 2004, Hepatology.

[25]  C. Mayr,et al.  miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely , 2007, Proceedings of the National Academy of Sciences.

[26]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[27]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[28]  C. Croce,et al.  Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. , 2008, Cancer research.

[29]  Yangde Zhang,et al.  miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. , 2011, Cancer letters.

[30]  J. Stamler,et al.  NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. , 1995, Archives of biochemistry and biophysics.

[31]  P. Galle,et al.  High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. , 2009, World journal of gastroenterology.

[32]  Manuel A. S. Santos,et al.  MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells , 2009, Proceedings of the National Academy of Sciences.

[33]  Anton J. Enright,et al.  Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.

[34]  E. B. Tahara,et al.  Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. , 2009, Free radical biology & medicine.

[35]  J. Mendell.  miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.

[36]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[37]  Robert E. Brown,et al.  Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. , 2008, Oncology reports.

[38]  P. Jones,et al.  Evolution of the human diet: linking our ancestral diet to modern functional foods as a means of chronic disease prevention. , 2009, Journal of medicinal food.

[39]  B. Halliwell,et al.  Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. , 2001, Free radical biology & medicine.

[40]  R. Merriman,et al.  Genetic influences in nonalcoholic fatty liver disease. , 2006, Journal of clinical gastroenterology.

[41]  Matthias Merkenschlager,et al.  T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer , 2005, The Journal of experimental medicine.

[42]  Annick Harel-Bellan,et al.  A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease , 2011, Nature Genetics.

[43]  Stefanie Dimmeler,et al.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.

[44]  S. McCall,et al.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.

[45]  D. V. van Thiel,et al.  The use of donor fatty liver for liver transplantation: a challenge or a quagmire? , 1996, Journal of hepatology.

[46]  D. Merlin,et al.  Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98 , 2012, Cellular and Molecular Life Sciences.

[47]  T. Dalmay,et al.  MicroRNAs and the hallmarks of cancer , 2006, Oncogene.

[48]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[49]  Monika Belickova,et al.  Differential expression of microRNAs in hematopoietic cell lineages , 2008, European journal of haematology.

[50]  Phillip A. Sharp,et al.  miRNA Profiling of Naïve, Effector and Memory CD8 T Cells , 2007, PloS one.

[51]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[52]  B. Cullen,et al.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.

[53]  Chris Sander,et al.  MicroRNA profiling of the murine hematopoietic system , 2005, Genome Biology.

[54]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[55]  K. Basso,et al.  Identification of the human mature B cell miRNome. , 2009, Immunity.

[56]  David Baltimore,et al.  MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.

[57]  P. Portincasa,et al.  Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: Results from humans and cholestatic rats , 2007, Hepatology.

[58]  Mark M. Davis,et al.  miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.

[59]  L. Flohé,et al.  Assays of glutathione peroxidase. , 1984, Methods in enzymology.

[60]  E. Abraham,et al.  miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses , 2009, Proceedings of the National Academy of Sciences.

[61]  F. Gonzalez,et al.  Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor γ1 (PPARγ1) Overexpression* , 2003, The Journal of Biological Chemistry.

[62]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[63]  S. Caldwell,et al.  The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis , 2004, Hepatology.

[64]  P. Portincasa,et al.  Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. , 2008, The Journal of nutritional biochemistry.

[65]  Moshe Oren,et al.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.

[66]  T. Tomasi,et al.  Dicer is regulated by cellular stresses and interferons. , 2009, Molecular immunology.

[67]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[68]  D. Valle,et al.  DNA methylation regulates microRNA expression , 2007, Cancer biology & therapy.

[69]  Anton J. Enright,et al.  microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. , 2007, Immunity.

[70]  G. Nicolson,et al.  Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function , 2007, Journal of cellular biochemistry.

[71]  E. Nisoli,et al.  A critical reflection on the definition of metabolic syndrome. , 2006, Pharmacological research.

[72]  S. Dalal,et al.  The Role of MicroRNA in Inflammatory Bowel Disease. , 2010, Gastroenterology & hepatology.

[73]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[74]  G. Calamita,et al.  Severe liver steatosis correlates with nitrosative and oxidative stress in rats , 2008, European journal of clinical investigation.

[75]  B. Kroesen,et al.  miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes , 2009, Laboratory Investigation.

[76]  A. Kowaltowski,et al.  Mitochondrial ATP‐sensitive K+ channel opening decreases reactive oxygen species generation , 2003, FEBS letters.

[77]  Ladan Fazli,et al.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development , 2007, Proceedings of the National Academy of Sciences.

[78]  C. Croce,et al.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. , 2009, Blood.

[79]  H. Grosshans,et al.  MicroRNA turnover: when, how, and why. , 2012, Trends in biochemical sciences.

[80]  Y. Furukawa,et al.  Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8 , 2012, EMBO reports.

[81]  E. Furth,et al.  Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.

[82]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[83]  C. Mackay,et al.  The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. , 2009, Immunity.

[84]  D. Conrad.  Faculty Opinions recommendation of Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. , 2008 .

[85]  R. Shiekhattar,et al.  The Microprocessor complex mediates the genesis of microRNAs , 2004, Nature.

[86]  A. Esquela-Kerscher,et al.  The complexities of microRNA regulation: mirandering around the rules. , 2010, The international journal of biochemistry & cell biology.

[87]  H. Hermeking.  The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.

[88]  S. Srinivasan,et al.  MicroRNAs determine human intestinal epithelial cell fate. , 2010, Differentiation; research in biological diversity.

[89]  Burton E. Barnett,et al.  Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation , 2009, Science.

[90]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[91]  T. Slater,et al.  The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents. , 1971, The Biochemical journal.

[92]  Anne Gatignol,et al.  TRBP, a regulator of cellular PKR and HIV‐1 virus expression, interacts with Dicer and functions in RNA silencing , 2005, EMBO reports.

[93]  Kenichi Sugihara,et al.  Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters , 2012, Clinical Cancer Research.

[94]  H. Nakagama,et al.  MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis. , 2010, Mutation research.

[95]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[96]  F. Slack,et al.  rna interference and micro rna –oriented therapy in cancer: rationales, promises, and challenges , 2009, Current oncology.

[97]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[98]  F. Marra,et al.  Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. , 2009, Journal of hepatology.

[99]  Y. Vodovotz,et al.  Convenient colorimetric and fluorometric assays for S-nitrosothiols. , 1996, Analytical biochemistry.

[100]  Hana Lee,et al.  Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. , 2009, Immunity.

[101]  F. Tietze.  Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.

[102]  Aadel A. Chaudhuri,et al.  Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder , 2008, The Journal of experimental medicine.

[103]  V. Tarasov,et al.  Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.

[104]  Klaus Rajewsky,et al.  MicroRNA Control in the Immune System: Basic Principles , 2009, Cell.

[105]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[106]  M. Siomi,et al.  Posttranscriptional regulation of microRNA biogenesis in animals. , 2010, Molecular cell.

[107]  H. Snoeck.  Faculty Opinions recommendation of MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. , 2007 .

[108]  Hiroshi I. Suzuki,et al.  Modulation of microRNA processing by p53 , 2009, Nature.

[109]  H. Nakamura,et al.  Redox regulation of cellular activation. , 1997, Annual review of immunology.

[110]  P. Klatt,et al.  Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. , 2000, European journal of biochemistry.

[111]  Qing Xu,et al.  MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF , 2012, Cell cycle.

[112]  Ryan M. O’Connell,et al.  MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. , 2010, Immunity.

[113]  A. Liston,et al.  MicroRNA in the immune system, microRNA as an immune system , 2009, Immunology.

[114]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[115]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[116]  X. Chen,et al.  Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.

[117]  Michael T. McManus,et al.  Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity , 2008, The Journal of experimental medicine.

[118]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[119]  R. Shiekhattar,et al.  TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing , 2005, Nature.

[120]  U. Kutay,et al.  Nuclear Export of MicroRNA Precursors , 2004, Science.

[121]  Susan R. Quinn,et al.  IL-10 Inhibits miR-155 Induction by Toll-like Receptors* , 2010, The Journal of Biological Chemistry.

[122]  Y Yang,et al.  MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer , 2013, Oncogene.

[123]  S. Dahan,et al.  MicroRNA-7 Modulates CD98 Expression during Intestinal Epithelial Cell Differentiation* , 2009, The Journal of Biological Chemistry.

[124]  N. Rajewsky,et al.  Dicer Ablation Affects Antibody Diversity and Cell Survival in the B Lymphocyte Lineage , 2008, Cell.

[125]  F. Bellanti,et al.  A Silybin-Phospholipid Complex Prevents Mitochondrial Dysfunction in a Rodent Model of Nonalcoholic Steatohepatitis , 2010, Journal of Pharmacology and Experimental Therapeutics.

[126]  D. Ceccarelli,et al.  Antioxidant activity of silybin in vivo during long-term iron overload in rats. , 1995, Gastroenterology.

[127]  Jiuhong Kang,et al.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.

[128]  T. Veenstra,et al.  Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. , 2008, Gastroenterology.

[129]  L. O’Neill,et al.  MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.

[130]  J. Nardone,et al.  Foxp1 is an essential transcriptional regulator of B cell development , 2006, Nature Immunology.

[131]  Raquel Díaz,et al.  Deregulated expression of miR‐106a predicts survival in human colon cancer patients , 2008, Genes, chromosomes & cancer.

[132]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[133]  A. Mantovani,et al.  Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals , 2009, Proceedings of the National Academy of Sciences.

[134]  A. Diehl,et al.  Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[135]  Shinobu Ueda,et al.  miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer , 2011, Cancer science.

[136]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[137]  P. Portincasa,et al.  Non-alcoholic fatty liver disease in the metabolic syndrome. , 2007, Current pharmaceutical design.

[138]  R. Shiekhattar,et al.  Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing , 2005, Cell.

[139]  F. Colina,et al.  Uric acid and anti‐TNF antibody improve mitochondrial dysfunction in ob/ob mice , 2006, Hepatology.

[140]  A. Kowaltowski,et al.  Tissue protection mediated by mitochondrial K+ channels. , 2006, Biochimica et biophysica acta.

[141]  George A Calin,et al.  Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing , 2011, Proceedings of the National Academy of Sciences.

[142]  B. Z. Altunkaynak,et al.  Overweight and structural alterations of the liver in female rats fed a high-fat diet: a stereological and histological study. , 2009, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[143]  H. Sültmann,et al.  The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. , 2007, Cancer research.

[144]  F. Slack,et al.  Small non-coding RNAs in animal development , 2008, Nature Reviews Molecular Cell Biology.

[145]  E. Pålsson-McDermott,et al.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.

[146]  A. di Sario,et al.  Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[147]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[148]  T. Billiar,et al.  Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. , 2005, Journal of the American Chemical Society.

[149]  F. Slack,et al.  MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.

[150]  E. Araki,et al.  Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. , 2007, Diabetes research and clinical practice.

[151]  S. Brant,et al.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. , 2008, Gastroenterology.

[152]  Qing Xu,et al.  MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis , 2011, Nucleic acids research.

[153]  S. Brant,et al.  Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohn's disease , 2011, Inflammatory bowel diseases.

[154]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[155]  D. Pessayre,et al.  Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. , 2006, Mitochondrion.

[156]  A. Kowaltowski,et al.  Effects of a high fat diet on liver mitochondria: increased ATP-sensitive K+ channel activity and reactive oxygen species generation , 2010, Journal of bioenergetics and biomembranes.

[157]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[158]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[159]  Lisa M Yerian,et al.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.

[160]  D. Brown,et al.  The promise of microRNA replacement therapy. , 2010, Cancer research.

[161]  H. Zhu,et al.  Mitochondrial adaptations to obesity-related oxidant stress. , 2000, Archives of biochemistry and biophysics.

[162]  J. Nardone,et al.  Foxp1 is an essential transcriptional regulator of B cell development , 2006, Nature Immunology.

[163]  K. Rajewsky,et al.  Aberrant T cell differentiation in the absence of Dicer , 2005, The Journal of experimental medicine.

[164]  P. Morazzoni,et al.  Comparative pharmacokinetics of silipide and silymarin in rats , 1993, European Journal of Drug Metabolism and Pharmacokinetics.

[165]  A. Rudensky,et al.  The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease , 2008, The Journal of Experimental Medicine.

[166]  Y. Naito,et al.  Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis , 2010, Journal of gastroenterology and hepatology.

[167]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[168]  B. Jiang,et al.  Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis. , 2008, Cancer research.

[169]  G. Dalmasso,et al.  Microbiota Modulate Host Gene Expression via MicroRNAs , 2011, PloS one.

[170]  F. Agani,et al.  Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α, HDM2, and p70S6K1 in Response to Phosphatidylinositol 3-Kinase/AKT Signaling* , 2004, Journal of Biological Chemistry.

[171]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[172]  R. Xu,et al.  Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study , 2008, The American Journal of Gastroenterology.

[173]  Toshiaki Watanabe,et al.  Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer , 2011, Oncology.

[174]  S. Shen,et al.  MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. , 2012, Acta biochimica et biophysica Sinica.

[175]  P. Portincasa,et al.  Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin‐induced anemia , 2005, Clinical pharmacology and therapeutics.

[176]  K. Czaplinski,et al.  Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. , 2004, RNA.

[177]  S. Linder.  Cytokeratin Markers Come of Age , 2007, Tumor Biology.

[178]  N Dubin,et al.  Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[179]  K. Wellington,et al.  Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders , 2012, BioDrugs.

[180]  Ryan M. O’Connell,et al.  Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.

[181]  E. Ulukaya,et al.  Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. , 2007, World journal of gastroenterology.

[182]  A. Kowaltowski,et al.  Redox properties of the adenoside triphosphate‐sensitive K+ channel in brain mitochondria , 2008, Journal of neuroscience research.

[183]  A. Dunne,et al.  Adaptor usage and Toll‐like receptor signaling specificity , 2005, FEBS letters.

[184]  G. Hannon,et al.  Processing of primary microRNAs by the Microprocessor complex , 2004, Nature.